Search results for ‘Subject term:"mental health problems"’ Sort:
Results 1 - 1 of 1
Regulatory policies on medicines for psychiatric disorders: is Europe on target?
- Authors:
- BARBUI Corrado, GARATTINI Silvio
- Journal article citation:
- British Journal of Psychiatry, 190(2), February 2007, pp.91-93.
- Publisher:
- Cambridge University Press
The European Medicines Agency (EMEA) is the regulatory body that provides the institutions of the European Community with the best possible scientific advice on the quality, safety and efficacy of medicinal products. Drugs approved by the EMEA are automatically marketable in all the European member states. Since the beginning of the EMEA’s activities a number of drugs acting on the central nervous system obtained marketing authorisation. This paper highlights some aspects of the EMEA rules that may negatively affect the evaluation of medicines for psychiatric disorders.